Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs AGNC Investment Corp (AGNC) Price & Performance

AbCellera Biologics IncTrade
AGNC Investment CorpTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs AGNC Investment Corp — how do they compare? AbCellera Biologics Inc trades at $9.21 (market cap $2.99B), while AGNC Investment Corp trades at $10.9 (market cap $12.91B). The key difference: AGNC Investment Corp is far larger — about 4.3× AbCellera Biologics Inc's market cap, and AGNC Investment Corp pays a 13.22% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLAGNC
Market Cap
$2.99B$12.91B
Sector
HealthFinancials
52-Week High
$9.76$12.17
52-Week Low
$2.78$9.46
Enterprise Value
$2.58B
Dividend Yield
13.22%

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About AGNC Investment Corp

AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage or real estate markets.

Read more on AGNC